StockTipsArenaBeta

BUY Marksans Pharma Limited — Vinay Rajani, HDFC Securities

BUYMarksans Pharma Limited

byVinay Rajani, HDFC SecuritiesHorizon: Swing (≤2wk)24 Sept 2026via NDTV Profit (Live)

Entry₹345.8Inferred
Target₹370
Total upside +7.00%
Stop loss₹326-5.73% risk
CMP₹334.6Just now
Active-3.24%+10.58%upside left 13d left
Follow Vinay Rajani for new calls(24% target hit, 50 closed calls)Get alertsWatch MARKSANS for new buy/sell callsGet alertsSee 279 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Sept, 12:05 pm IST
1 supporting2 neutral1 opposing
Supports the BUY call (1)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·18 Aug · 1mo ago

Neutral / worth noting (2)

Marksans Pharma Opens SEBI-Mandated Window for Re-Lodging Physical Share Transfers

NewsGoogle News·17 Sept · 1w ago

(opens in new tab)

Marksans Pharma opens special window for re-lodgement of physical share transfer requests

NewsGoogle News·17 Sept · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·25 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.